CANY
PODD icon

Caxton Associates (New York)’s Insulet PODD Stock Holding History

Caxton Associates (New York)’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3,964
Closed -$340K – 515
2018
Q2 		$340K Buy
+3,964
New +$356K 0.02% 298

Other funds holding PODD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Caxton Associates (New York)'s PODD Position: Q3 2018 in Review

Caxton Associates (New York) sold out of Insulet (PODD) in Q3 2018, closing a stake of 3,964 shares — an estimated $340K sold.

Caxton Associates (New York) first reported a position in PODD in Q2 2018 and held it in 1 quarter. The position peaked at $340K in Q2 2018. 237 funds tracked by Wall St. Rank hold PODD as of Q3 2018.

  • Caxton Associates (New York) reported no remaining Insulet position as of Q3 2018 after selling out during the quarter.
  • Caxton Associates (New York) sold 3,964 Insulet shares in Q3 2018, an estimated $340K.
  • Caxton Associates (New York) first reported a position in Insulet in Q2 2018 and held it in 1 quarter.
  • Caxton Associates (New York)'s Insulet position peaked at $340K in Q2 2018.
  • 237 funds tracked by Wall St. Rank held Insulet as of Q3 2018.

Based on Caxton Associates (New York)'s 13F filing for Q3 2018, filed 14 Nov 2018.